• Users Online: 352
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2019  |  Volume : 2  |  Issue : 2  |  Page : 71-74

Summary of 'Hemolytic uremic syndrome in a developing country: Consensus guidelines'


1 Department of Pediatrics, Calcutta Medical Research Institute, Kolkata, West Bengal, India
2 Renal Unit, King Edward Memorial Hospital, Pune, Maharashtra, India

Correspondence Address:
Jyoti Sharma
Renal Unit, King Edward Memorial Hospital, Pune - 411 011, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/AJPN.AJPN_21_19

Rights and Permissions

Hemolytic uremic syndrome (HUS) is a common cause of acute kidney injury in children and has implications of irreversible renal damage. The management depends on the etiology of HUS. Guidelines for India have been formulated to arrive at the etiology with an algorithmic approach based on the epidemiology and the constraints of facilities available for investigations and therapy in the region. Anti-Factor H antibody-associated illness accounts for over half the cases of atypical HUS (aHUS) in Indian children, and prompt plasma exchange and immunosuppression are recommended to lower antibody levels. Since access to eculizumab is limited, the management of other forms of aHUS relies on plasma therapy. Indications for biopsy and concerns around kidney transplantation are highlighted. A brief comparison with current guidelines from other regions has been made.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed898    
    Printed84    
    Emailed0    
    PDF Downloaded239    
    Comments [Add]    

Recommend this journal